Tagayan, Nor-aiza U.
HRN: 01-70-80 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/22/2025
AMPICILLIN 1GM (VIAL)
09/22/2025
09/24/2025
IVTT
2g
Q6hours
Thinly MSAF
Waiting Final Action
Indication: Prophylaxis Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes